Durata Therapeutics, Inc. EBITDA
Durata Therapeutics, Inc. EBITDA
- 2014-09-30: Basis Reported; EBITDA (m); Operating income -$18.26M; Depreciation and amortization (m).
- 2014-06-30: Basis Reported; EBITDA (m); Operating income -$18.79M; Depreciation and amortization (m).
- 2014-03-31: Basis Reported; EBITDA (m); Operating income -$18.94M; Depreciation and amortization (m).
- 2013-12-31: Basis Reported; EBITDA (m); Operating income -$12.55M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2014-09-30 | Reported | (m) | -$18.26M | (m) | (m) | (m) | (m) | (m) | (m) | $11.27M | $16.70M | $207.00K |
|---|
| 2014-06-30 | Reported | (m) | -$18.79M | (m) | (m) | (m) | (m) | (m) | (m) | $6.19M | (m) | -$1.79M |
|---|
| 2014-03-31 | Reported | (m) | -$18.94M | (m) | (m) | (m) | (m) | (m) | (m) | $9.01M | (m) | $131.00K |
|---|
| 2013-12-31 | Reported | (m) | -$12.55M | (m) | (m) | (m) | (m) | (m) | (m) | $7.12M | (m) | $563.00K |
|---|
| 2013-09-30 | Reported | (m) | -$11.02M | (m) | (m) | (m) | (m) | (m) | (m) | $5.93M | $4.82M | $257.00K |
|---|
| 2013-06-30 | Reported | (m) | -$17.98M | (m) | (m) | (m) | (m) | (m) | (m) | $13.18M | (m) | $210.00K |
|---|
| 2013-03-31 | Reported | (m) | -$15.43M | (m) | (m) | (m) | $402.00K | (m) | (m) | $11.09M | (m) | $248.00K |
|---|
| 2012-12-31 | Reported | (m) | -$13.34M | (m) | (m) | (m) | (m) | (m) | (m) | $9.44M | (m) | (m) |
|---|
| 2012-09-30 | Reported | (m) | -$21.79M | (m) | (m) | (m) | (m) | (m) | (m) | $18.96M | (m) | (m) |
|---|
| 2012-06-30 | Reported | (m) | -$19.19M | (m) | (m) | (m) | (m) | (m) | (m) | $16.53M | (m) | (m) |
|---|
| 2012-03-31 | Reported | (m) | -$8.26M | (m) | (m) | (m) | (m) | (m) | (m) | $6.77M | (m) | (m) |
|---|
| 2011-12-31 | Reported | (m) | $10.79M | (m) | (m) | (m) | (m) | (m) | (m) | $9.04M | (m) | $1.02M |
|---|
| 2011-09-30 | Reported | (m) | $10.09M | (m) | (m) | (m) | (m) | (m) | (m) | $8.33M | (m) | $706.36K |
|---|
| 2011-06-30 | Reported | (m) | $12.07M | (m) | (m) | (m) | (m) | (m) | (m) | $8.44M | (m) | $605.70K |
|---|
| 2011-03-31 | Reported | (m) | $2.60M | (m) | (m) | (m) | (m) | (m) | (m) | $4.33M | (m) | $176.59K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2014-09-30 | Rolling | (m) | -$68.55M* | (m) | (m) | (m) | (m) | (m) | (m) | $33.58M* | (m) | -$886.00K* |
|---|
| 2014-06-30 | Rolling | (m) | -$61.30M* | (m) | (m) | (m) | (m) | (m) | (m) | $28.24M* | (m) | -$836.00K* |
|---|
| 2014-03-31 | Rolling | (m) | -$60.49M* | (m) | (m) | (m) | (m) | (m) | (m) | $35.23M* | (m) | $1.16M* |
|---|
| 2013-12-31 | Reported | (m) | -$56.97M | (m) | (m) | (m) | $445.00K | (m) | (m) | $37.32M | (m) | $1.28M |
|---|
| 2013-12-31 | Rolling | (m) | -$56.97M* | (m) | (m) | (m) | (m) | (m) | (m) | $37.32M* | (m) | $1.28M* |
|---|
| 2013-09-30 | Rolling | (m) | -$57.77M* | (m) | (m) | (m) | (m) | (m) | (m) | $39.64M* | (m) | (m) |
|---|
| 2013-06-30 | Rolling | (m) | -$68.54M* | (m) | (m) | (m) | (m) | (m) | (m) | $52.67M* | (m) | (m) |
|---|
| 2013-03-31 | Rolling | (m) | -$69.75M* | (m) | (m) | (m) | (m) | (m) | (m) | $56.02M* | (m) | (m) |
|---|
| 2012-12-31 | Reported | (m) | -$62.58M | (m) | (m) | (m) | $719.00K | (m) | (m) | $51.70M | (m) | $0.00 |
|---|
| 2012-12-31 | Rolling | (m) | -$62.58M* | (m) | (m) | (m) | (m) | (m) | (m) | $51.70M* | (m) | (m) |
|---|
| 2012-09-30 | Rolling | (m) | -$38.44M* | (m) | (m) | (m) | (m) | (m) | (m) | $51.29M* | (m) | (m) |
|---|
| 2012-06-30 | Rolling | (m) | -$6.56M* | (m) | (m) | (m) | (m) | (m) | (m) | $40.66M* | (m) | (m) |
|---|
| 2012-03-31 | Rolling | (m) | $24.70M* | (m) | (m) | (m) | (m) | (m) | (m) | $32.57M* | (m) | (m) |
|---|
| 2011-12-31 | Reported | (m) | -$35.56M | (m) | (m) | (m) | (m) | (m) | (m) | $30.13M | (m) | -$2.51M |
|---|
| 2011-12-31 | Rolling | (m) | $35.56M* | (m) | (m) | (m) | (m) | (m) | (m) | $30.13M* | (m) | $2.51M* |
|---|
| 2010-12-31 | Reported | (m) | $13.89M | (m) | (m) | (m) | (m) | (m) | (m) | $4.82M | (m) | $2.88M |
|---|